C16030
Completed
A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
Clinicaltrials.gov
#NCT04840680About this clinical trial
In this study, people with MM will be treated with ixazomib citrate according to their clinic's standard practice. The main aim of the study is to check for side effects from ixazomib citrate.
KR
Observational clinical trial.
At a glance
What medical conditions were being studied?
Multiple Myeloma
What was the clinical trial testing?
No Intervention
How many participants were enrolled?
191
Were placebos part of the clinical trial?
No
When was the clinical trial conducted?
Mar 2021 - Aug 2023
How long was participation in the clinical trial?
Each participant will be in the study for about 6 months.
Key requirements
Sexes
All
Age
All
Healthy volunteers?
No
Entry criteria
Both men and women can take part.
Must have multiple myeloma.
Must be being treated with ixazomib citrate according to the product label.